{"id":"tc99m-sestamibi","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure"},{"rate":"<1%","effect":"Allergic reaction (rare)"}]},"_chembl":null,"_dailymed":{"setId":"8626e756-767a-4a14-9188-658b58185254","title":"KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH 414, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tc-99m sestamibi is a lipophilic cationic complex that crosses cell membranes and localizes in mitochondria based on the negative membrane potential of viable cells. The radioisotope Tc-99m emits gamma radiation that is detected by gamma cameras, enabling single-photon emission computed tomography (SPECT) imaging. Differential uptake between ischemic and normally perfused myocardium allows assessment of coronary artery disease and myocardial viability.","oneSentence":"Tc-99m sestamibi is a radiotracer that accumulates in mitochondria of viable cells, allowing visualization of myocardial perfusion and detection of ischemia via nuclear imaging.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:26:19.332Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial perfusion imaging for detection of coronary artery disease"},{"name":"Assessment of myocardial viability"},{"name":"Evaluation of left ventricular function"}]},"trialDetails":[{"nctId":"NCT03996850","phase":"","title":"SPECT/CT for the Characterization of Renal Masses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2018-12-07","conditions":"Kidney Neoplasm, Renal Mass","enrollment":102},{"nctId":"NCT02324387","phase":"NA","title":"Tc99m Sestamibi Molecular Breast Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06-15","conditions":"Breast Cancer","enrollment":96},{"nctId":"NCT03220893","phase":"NA","title":"Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-06-14","conditions":"Breast Carcinoma","enrollment":3023},{"nctId":"NCT05042687","phase":"NA","title":"Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-13","conditions":"Breast Cancer","enrollment":300},{"nctId":"NCT02744053","phase":"EARLY_PHASE1","title":"DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-11-07","conditions":"Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative","enrollment":96},{"nctId":"NCT06058650","phase":"NA","title":"Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-08-26","conditions":"Breast Neoplasm","enrollment":70},{"nctId":"NCT05891769","phase":"PHASE2, PHASE3","title":"99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT","status":"RECRUITING","sponsor":"Andrei Iagaru","startDate":"2023-09-27","conditions":"Parathyroid Adenoma","enrollment":100},{"nctId":"NCT05299632","phase":"","title":"F-18 PSMA for Localization of Parathyroid Adenoma","status":"TERMINATED","sponsor":"Emory University","startDate":"2022-03-31","conditions":"Hyperparathyroidism","enrollment":3},{"nctId":"NCT01899833","phase":"PHASE2","title":"Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)","status":"NOT_YET_RECRUITING","sponsor":"Cell>Point LLC","startDate":"2025-05-10","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT05728957","phase":"","title":"Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors","status":"RECRUITING","sponsor":"Loyola University","startDate":"2023-02-01","conditions":"Kidney Tumor, Renal Benign Neoplasm, Renal Malignant Tumor","enrollment":100},{"nctId":"NCT01334918","phase":"PHASE2","title":"A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2011-04-26","conditions":"Coronary Artery Disease (CAD)","enrollment":124},{"nctId":"NCT00826280","phase":"PHASE3","title":"Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-03-24","conditions":"Coronary Artery Disease (CAD)","enrollment":347},{"nctId":"NCT04316845","phase":"NA","title":"18F-fluorocholine PET/CT for Hyperparathyroidism","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-01-16","conditions":"Hyperparathyroidism","enrollment":38},{"nctId":"NCT04583787","phase":"NA","title":"xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-12-07","conditions":"Coronary Artery Disease","enrollment":52},{"nctId":"NCT04040946","phase":"PHASE3","title":"Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2019-09-19","conditions":"Parathyroid Adenoma, Hyperparathyroidism, F18-choline","enrollment":59},{"nctId":"NCT00560495","phase":"PHASE1","title":"Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2007-05","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT03065218","phase":"PHASE4","title":"99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2016-10","conditions":"Thyroid Cancer","enrollment":4},{"nctId":"NCT02749045","phase":"NA","title":"Simultaneous Assessment of FFR and SPECT","status":"TERMINATED","sponsor":"Prem Soman","startDate":"2016-07","conditions":"Coronary Artery Disease","enrollment":27},{"nctId":"NCT05146323","phase":"","title":"Optimization of 99mTc-Sestamibi Activities in SPECT/CT Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2021-02-11","conditions":"Coronary Heart Disease","enrollment":294},{"nctId":"NCT01347710","phase":"PHASE3","title":"A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2011-06","conditions":"Coronary Artery Disease","enrollment":795},{"nctId":"NCT03082456","phase":"NA","title":"Molecular Breast Imaging in Screening Breast Cancer","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-06-01","conditions":"Breast Cancer","enrollment":164},{"nctId":"NCT02160925","phase":"NA","title":"Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-05","conditions":"Clinical T1 Renal Mass","enrollment":125},{"nctId":"NCT00162032","phase":"PHASE3","title":"A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-08","conditions":"Kawasaki Disease","enrollment":445},{"nctId":"NCT02428335","phase":"","title":"Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib","status":"WITHDRAWN","sponsor":"AHS Cancer Control Alberta","startDate":"2015-06","conditions":"Renal Cell Cancer, Fatigue","enrollment":""},{"nctId":"NCT03555487","phase":"PHASE3","title":"Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-05-05","conditions":"Parathyroid Diseases","enrollment":103},{"nctId":"NCT01653964","phase":"NA","title":"Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-07","conditions":"Breast Cancer","enrollment":83},{"nctId":"NCT01545622","phase":"","title":"Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2008-03","conditions":"Parathyroid Disease","enrollment":61},{"nctId":"NCT01944215","phase":"PHASE1","title":"Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-09","conditions":"Molecular Imaging","enrollment":154},{"nctId":"NCT03040700","phase":"NA","title":"Follow-up of Patients With Multivessel Coronary Artery Disease After CABG","status":"UNKNOWN","sponsor":"Ministry of Health, Brazil","startDate":"2014-11","conditions":"Coronary (Artery); Disease","enrollment":600},{"nctId":"NCT02869126","phase":"NA","title":"Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2012-09","conditions":"Myocardial Perfusion","enrollment":118},{"nctId":"NCT01434641","phase":"NA","title":"Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2011-07","conditions":"Coronary Artery Disease","enrollment":102},{"nctId":"NCT01499654","phase":"NA","title":"Half-Dose Radiopharmaceutical in Wide Beam Reconstruction","status":"TERMINATED","sponsor":"Edwin Wu","startDate":"2011-10","conditions":"Myocardial Infarction, Ischemic Heart Disease","enrollment":64},{"nctId":"NCT01019486","phase":"PHASE4","title":"Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2009-11","conditions":"Coronary Artery Disease, Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT00705458","phase":"NA","title":"Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2008-07","conditions":"Coronary Artery Disease, Angina Pectoris, Unstable Angina","enrollment":400},{"nctId":"NCT02524600","phase":"NA","title":"Technical Performance of a New Cardiac Technology \"IQ-SPECT\" Applied to SCINTI-CT Myocardial Imaging With 99mTc-Sestamibi in Coronary Patients","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2012-01","conditions":"Coronary Artery Disease","enrollment":103},{"nctId":"NCT02024074","phase":"PHASE1","title":"Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients","status":"TERMINATED","sponsor":"Emory University","startDate":"2013-11","conditions":"Breast Cancer","enrollment":1},{"nctId":"NCT01387152","phase":"","title":"Prognosis of Very Low Dose SPECT","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-11","conditions":"Chest Pain","enrollment":100},{"nctId":"NCT02013726","phase":"NA","title":"MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue","status":"WITHDRAWN","sponsor":"Gamma Medica, Inc.","startDate":"2015-04","conditions":"Breast Neoplasms","enrollment":""},{"nctId":"NCT01925170","phase":"NA","title":"Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-04","conditions":"Breast Cancer","enrollment":1638},{"nctId":"NCT00620373","phase":"NA","title":"Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2005-08","conditions":"Breast Cancer","enrollment":969},{"nctId":"NCT01379677","phase":"PHASE3","title":"Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison","status":"COMPLETED","sponsor":"Advanced Accelerator Applications","startDate":"2011-02","conditions":"Coronary Artery Disease","enrollment":135},{"nctId":"NCT01373944","phase":"","title":"Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI","status":"COMPLETED","sponsor":"Aspire Foundation","startDate":"2010-05","conditions":"Coronary Artery Disease","enrollment":500},{"nctId":"NCT01027767","phase":"","title":"Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-05","conditions":"Breast Cancer","enrollment":23},{"nctId":"NCT00069160","phase":"PHASE2","title":"Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-09","conditions":"Lung Neoplasms, Ovarian Neoplasms, Cervix Neoplasms","enrollment":48},{"nctId":"NCT00972205","phase":"NA","title":"Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-12","conditions":"Cervical, Ovarian, Lung","enrollment":12},{"nctId":"NCT01368939","phase":"","title":"Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2012-03","conditions":"Breast Lesions","enrollment":150},{"nctId":"NCT00804544","phase":"NA","title":"99mTc-MIBI SPECT/CT in Breast Malignancy","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-09","conditions":"Breast Cancer","enrollment":4},{"nctId":"NCT00943527","phase":"","title":"Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-01","conditions":"Breast Cancer","enrollment":110},{"nctId":"NCT00566280","phase":"NA","title":"Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-10","conditions":"Breast Cancer, Bloody Nipple Discharge","enrollment":14},{"nctId":"NCT00566085","phase":"NA","title":"New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-01","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT00162045","phase":"PHASE1, PHASE2","title":"A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-01","conditions":"Kawasaki Disease","enrollment":79},{"nctId":"NCT00162331","phase":"PHASE4","title":"CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-01","conditions":"Myocardial Infarction","enrollment":74},{"nctId":"NCT00162357","phase":"PHASE4","title":"Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2004-04","conditions":"Diabetes Mellitus, Type 2, Coronary Restenosis","enrollment":106},{"nctId":"NCT00162344","phase":"PHASE4","title":"A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2003-12","conditions":"Diabetes","enrollment":205},{"nctId":"NCT01047150","phase":"","title":"The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi","status":"UNKNOWN","sponsor":"Cardiac Imaging of Augusta","startDate":"2010-01","conditions":"Myocardial Ischemia","enrollment":250},{"nctId":"NCT00769275","phase":"","title":"Detection of Ischemia in Asymptomatic Diabetics","status":"COMPLETED","sponsor":"Yale University","startDate":"2000-08","conditions":"Type 2 Diabetes Mellitus","enrollment":1123},{"nctId":"NCT00487812","phase":"NA","title":"Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2004-12","conditions":"Ischemic Heart Disease, Myocardial Infarction","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20090428","type":"ORIG","sponsor":"CARDINAL HEALTH 414","applicationNumber":"ANDA078809"},{"date":"20160110","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"ANDA078809"},{"date":"19960926","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970523","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19951214","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19920909","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20080430","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19901221","type":"ORIG","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20191204","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000211","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20020122","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970808","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970424","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19961108","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19951214","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19960228","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19920130","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000608","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000114","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19980610","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"}],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tc99m sestamibi","genericName":"Tc99m sestamibi","companyName":"M.D. Anderson Cancer Center","companyId":"m-d-anderson-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tc99m sestamibi is a radiopharmaceutical used in clinical trials to study various types of cancer, including cervical, ovarian, lung, breast, and renal cancer. It is also used in a pharmacodynamic study to investigate the function of P-glycoprotein, a protein involved in multidrug resistance in cancer cells.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"1990-12-21T00:00:00.000Z","mah":"SHINE","brand_name_local":null,"application_number":"NDA019785"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2009-04-28T00:00:00.000Z","mah":"CARDINAL HEALTH 414","brand_name_local":null,"application_number":"ANDA078809"}],"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}